Transforming growth factor-β superfamily, implications in development and differentiation of stem cells

Biomolecular Concepts

Volumn 3, Issue 5, 2012, Pages 429-445

  Santibanez, Juan F ^a   Kocic, Jelena ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

BMP; differentiation; signaling; stem cells; TGF

Indexed keywords

EID: 84893825375     PISSN: 18685021     EISSN: 1868503X     Source Type: Journal    
DOI: 10.1515/bmc-2012-0015     Document Type: Review

References (162)

1. Gordon KJ, Blobe GC. Role of transforming growth factor-?superfamily signaling pathways in human disease. Biochim Biophys Acta 2008; 1782: 197-228.
2. Santibañez JF, Quintanilla M, Bernabeu C. TGF-?/TGF-?receptor system and its role in physiological and pathological conditions. Clin Sci (Lond) 2011; 121: 233-51.
3. Derynck R, Akhurst RJ. Differentiation plasticity regulated by TGF-?family proteins in development and disease. Nat Cell Biol 2007; 9: 1000-4.
4. Horbelt D, Denkis A, Knaus P. A portrait of transforming growth factor ?superfamily signalling: Background matters. Int J Biochem Cell Biol 2012; 44: 469-74.
5. Galat A. Common structural traits for cystine knot domain of the TGF ?superfamily of proteins and three-fi ngered ectodomain of their cellular receptors. Cell Mol Life Sci 2011; 68: 3437-51.
6. Anzano MA, Roberts AB, Smith JM, Sporn MB, De Larco JE. Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type alpha and type beta transforming growth factors. Proc Natl Acad Sci USA 1983; 80: 6264-8.
7. Govinden R, Bhoola KD. Genealogy, expression, and cellular function of transforming growth factor-? Pharmacol Ther 2003; 98: 257-65
8. Birchenall-Roberts MC, Ruscetti FW, Kasper J, Lee HD, Friedman R, Geiser A, Sporn MB, Roberts AB, Kim SJ. Transcriptional regulation of the transforming growth factor beta 1 promoter by v-src gene products is mediated through the AP-1 complex. Mol Cell Biol 1990; 10: 4978-83.
9. Dey BR, Sukhatme VP, Roberts AB, Sporn MB, Rauscher FJ 3rd, Kim SJ. Repression of the transforming growth factor-beta 1 gene by the Wilms tumor suppressor WT1 gene product. Mol Endocrinol 1994; 8: 595-602.
10. Lafyatis R, Lechleider R, Kim SJ, Jakowlew S, Roberts AB, Sporn MB. Structural and functional characterization of the transforming growth factor beta 3 promoter. A cAMP-responsive element regulates basal and induced transcription. J Biol Chem 1990; 265: 19128-36.
11. OReilly MA, Geiser AG, Kim SJ, Bruggeman LA, Luu AX, Roberts AB, Sporn MB. Identification of an activating transcription factor (ATF) binding site in the human transforming growth factor-beta 2 promoter. J Biol Chem 1992; 267: 19938-43.
12. Roberts AB. Molecular and cell biology of TGF-beta. Miner Electrolyte Metab 1998; 24: 111-9.
13. Rifkin DB. Latent transforming growth factor-beta (TGF-beta) binding proteins: Orchestrators of TGF-beta availability. J Biol Chem 2005; 280: 7409-12.
14. Dubois CM, Laprise MH, Blanchette F, Gentry LE, Leduc R. Processing of transforming growth factor beta 1 precursor by human furin convertase. J Biol Chem 1995; 270: 10618-24.
15. Chaudhry SS, Cain SA, Morgan A, Dallas SL, Shuttleworth CA, Kielty CM. Fibrillin-1 regulates the bioavailability of TGFbeta1. J Cell Biol 2007; 176: 355-67.
16. Crawford SE, Stellmach V, Murphy-Ullrich JE, Ribeiro SM, Lawler J, Hynes RO, Boivin GP, Bouck N. Thrombospondin-1 is a major activator of TGF-beta1 in vivo. Cell 1998; 93: 1159-70.
17. Yu Q, Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 2000; 14: 163-76.
18. Munger JS, Harpel JG, Gleizes PE, Mazzieri R, Nunes I, Rifkin DB. Latent transforming growth factor-beta: Structural features and mechanisms of activation. Kidney Int 1997; 51: 1376-82.
19. Urist MR, Strates BS. Bone morphogenetic protein. J Dent Res 1971; 50: 1392-406.
20. Katagiri T, Suda T, Miyazono K. The bone morphogenetic proteins in the TGF-B family. In: Derynck R, Miyazono K, editors. The TGF-beta family. New York: Cold Spring Harbor Laboratory Press, 2008: 121-49.
21. Miyazono K, Kamiya Y, Morikawa M. Bone morphogenetic protein receptors and signal transduction. J Biochem 2010; 147: 35-51.
22. Hearn MT, Gomme PT. Molecular architecture and biorecognition processes of the cystine knot protein superfamily: Part I. The glycoprotein hormones. J Mol Recognit 2000; 13: 223-78.
23. Yanagita M. BMP modulators regulate the function of BMP during body patterning and disease progression. Biofactors 2009; 35: 113-9.
24. Rider CC, Mulloy B. Bone morphogenetic protein and growth differentiation factor cytokine families and their protein antagonists. Biochem J 2010; 429: 1-12.
25. Lin J, Patel SR, Cheng X, Cho EA, Levitan I, Ullenbruch M, Phan SH, Park JM, Dressler GR. Kielin/chordin-like protein, a novel enhancer of BMP signaling, attenuates renal fibrotic disease. Nat Med 2005; 11: 387-93.
26. Ikeya M, Kawada M, Kiyonari H, Sasai N, Nakao K, Furuta Y, Sasai Y. Essential pro-Bmp roles of crossveinless 2 in mouse organogenesis. Development 2006; 133: 4463-73.
27. Bragdon B, Moseychuk O, Saldanha S, King D, Julian J, Nohe A. Bone morphogenetic proteins: A critical review. Cell Signal 2011; 23: 609-20.
28. Katoh Y, Katoh M. Comparative integromics on BMP/GDF family. Int J Mol Med 2006; 17: 951-5.
29. Visser JA, de Jong FH, Laven JS, Themmen AP. Anti-Müllerian hormone: A new marker for ovarian function. Reproduction 2006; 131: 1-9.
30. di Clemente N, Josso N, Gou é dard L, Belville C. Components of the anti-Müllerian hormone signaling pathway in gonads. Mol Cell Endocrinol 2003; 211: 9-14.
31. Xia Y, Schneyer AL. The biology of activin: Recent advances in structure, regulation and function. J Endocrinol 2009; 202: 1-12.
32. Lin SJ, Lerch TF, Cook RW, Jardetzky TS, Woodruff TK. The structural basis of TGF-beta, bone morphogenetic protein, and activin ligand binding. Reproduction 2006; 132: 179-90.
33. Stenvers KL, Findlay JK. Inhibins: From reproductive hormones to tumor suppressors. Trends Endocrinol Metab 2010; 21: 174-80.
34. Nickel J, Sebald W, Groppe JC, Mueller TD. Intricacies of BMP receptor assembly. Cytokine Growth Factor Rev 2009; 20: 367-77.
35. Ehrlich M, Gutman O, Knaus P, Henis YI. Oligomeric interactions of TGF-?and BMP receptors. FEBS Lett 2012; 586: 1885-96.
36. Ehrlich M, Horbelt D, Marom B, Knaus P, Henis YI. Homomeric and heteromeric complexes among TGF-beta and BMP receptors and their roles in signaling. Cell Signal 2011; 23: 1424-32.
37. Bernabeu C, Lopez-Novoa JM, Quintanilla M. The emerging role of TGF-beta superfamily coreceptors in cancer. Biochim Biophys Acta 2009; 1792: 954-73.
38. Souchelnytskyi S, ten Dijke P, Miyazono K, Heldin CH. Phosphorylation of Ser165 in TGF-beta type I receptor modulates TGF-beta1-induced cellular responses. EMBO J 1996; 15: 6231-40.
39. Huse M, Chen YG, Massagu é J, Kuriyan J. Crystal structure of the cytoplasmic domain of the type I TGF beta receptor in complex with FKBP12. Cell 1999; 96: 425-36.
40. Huse M, Muir TW, Xu L, Chen YG, Kuriyan J, Massagu é J. The TGF beta receptor activation process: An inhibitor-To substratebinding switch. Mol Cell 2001; 8: 671-82.
41. Kang JS, Liu C, Derynck R. New regulatory mechanisms of TGF-beta receptor function. Trends Cell Biol 2009; 19: 385-94.
42. Shi W, Sun C, He B, Xiong W, Shi X, Yao D, Cao X. GADD34-PP1c recruited by Smad7 dephosphorylates TGFbeta type I receptor. J Cell Biol 2004; 164: 291-300.
43. Satow R, Kurisaki A, Chan T-C, Hamazaki TS, Asashima M. Dullard promotes degradation and dephosphorylation of BMP receptors and is required for neural induction. Dev Cell 2006; 11: 763-74.
44. Wang Y, Dasso M. SUMOylation and deSUMOylation at a glance. J Cell Sci 2009; 122: 4249-52.
45. Kang JS, Saunier EF, Akhurst RJ, Derynck R. The type I TGFbeta receptor is covalently modifi ed and regulated by sumoylation. Nat Cell Biol 2008; 10: 654-64.
46. Di Guglielmo GM, Le Roy C, Goodfellow AF, Wrana JL. Distinct endocytic pathways regulate TGF-beta receptor signalling and turnover. Nat Cell Biol 2003; 5: 410-21.
47. Kavsak P, Rasmussen RK, Causing CG, Bonni S, Zhu H, Thomsen GH, Wrana JL. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF b receptor for degradation. Mol Cell 2000; 6: 1365-75.
48. Ebisawa T, Fukuchi M, Murakami G, Chiba T, Tanaka K, Imamura T, Miyazono K. Smurf1 interacts with transforming growth factor-b type I receptor through Smad7 and induces receptor degradation. J Biol Chem 2001; 276: 12477-80.
49. Chang H, Brown CW, Matzuk MM. Genetic analysis of the mammalian transforming growth factor-beta superfamily. Endocr Rev 2002; 23: 787-823.
50. Shi Y, Massagu é J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003; 113: 685-700.
51. Tsukazaki T, Chiang TA, Davison AF, Attisano L, Wrana JL. SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor. Cell 1998; 95: 779-91.
52. Attisano L, Lee-Hoefl ich ST. The Smads. Genome Biol 2001; 2: REVIEWS3010.
53. Zhang Y, Feng X, We R, Derynck R. Receptor-Associated Mad homologues synergize as effectors of the TGF-beta response. Nature 1996; 383: 168-72.
54. Itoh S, ten Dijke P. Negative regulation of TGF-beta receptor/ Smad signal transduction. Curr Opin Cell Biol 2007; 19: 176-84.
55. Massague J, Chen YG. Controlling TGF-B signaling. Genes Dev 2000; 14: 627-44.
56. Miyazono K, Maeda S, Imamura T. BMP receptor signaling: Transcriptional targets, regulation of signals, and signaling crosstalk. Cytokine Growth Factor Rev 2005; 16: 251-63.
57. Morikawa M, Koinuma D, Tsutsumi S, Vasilaki E, Kanki Y, Heldin CH, Aburatani H, Miyazono K. ChIP-seq reveals cell type-specific binding patterns of BMP-specific Smads and a novel binding motif. Nucleic Acids Res 2011; 39: 8712-27.
58. Zhang YE. Non-Smad pathways in TGF-beta signaling. Cell Res 2009; 19: 128-39.
59. Mulder KM, Morris SL. Activation of p21ras by transforming growth factor beta in epithelial cells. J Biol Chem 1992; 267: 5029-31.
60. Lee MK, Pardoux C, Hall MC, Lee PS, Warburton D, Qing J, Smith SM, Derynck R. TGF-beta activates Erk MAP kinase signalling through direct phosphorylation of ShcA. EMBO J 2007; 26: 3957-67.
61. Sorrentino A, Thakur N, Grimsby S, Marcusson A, von Bulow V, Schuster N, Zhang S, Heldin CH, Landstrom M. The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner. Nat Cell Biol 2008; 10: 1199-207.
62. Yamashita M, Fatyo K, Jin C, Wang X, Liu Z, Zhang YE. TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-? Mol Cell 2008; 31: 918-24.
63. Moustakas A, Heldin CH. Signaling networks guiding epithelialmesenchymal transitions during embryogenesis and cancer progression. Cancer Sci 2007; 98: 1512-20.
64. Xu J, Lamouille S, Derynck R. TGF-beta-induced epithelial to mesenchymal transition. Cell Res 2009; 19: 156-72.
65. Konstantinidis G, Moustakas A, Stournaras C. Regulation of myosin light chain function by BMP signaling controls actin cytoskeleton remodeling. Cell Physiol Biochem 2011; 28: 1031-44.
66. Gamell C, Osses N, Bartrons R, Ruckle T, Camps M, Rosa JL, Ventura F: Bmp2 induction of actin cytoskeleton reorganization and cell migration requires pi3-kinase and cdc42 activity. J Cell Sci 2008; 121: 3960-70.
67. Wilkes MC, Mitchell H, Penheiter SG, Dor é JJ, Suzuki K, Edens M, Sharma DK, Pagano RE, Leof EB. Transforming growth factor-beta activation of phosphatidylinositol 3-kinase is independent of Smad2 and Smad3 and regulates fibroblast responses via p21-Activated kinase-2. Cancer Res 2005; 65: 10431-40.
68. Yi JY, Shin I, Arteaga CL. Type I transforming growth factor beta receptor binds to and activates phosphatidylinositol 3-kinase. J Biol Chem 2005; 280: 10870-6.
69. Chen RH, Su YH, Chuang RL, Chang TY. Suppression of transforming growth factor-beta-induced apoptosis through a phosphatidylinositol 3-kinase/Akt-dependent pathway. Oncogene 1998; 17: 1959-68.
70. Song K, Wang H, Krebs TL, Danielpour D. Novel roles of Akt and mTOR in suppressing TGF-beta/ALK5-mediated Smad3 activation. EMBO J 2006; 25: 58-69.
71. James D, Levine AJ, Besser D, Hemmati-Brivanlou A. TGFb/ activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. Development 2005; 132: 1273-82.
72. Smith AG. Embryo-derived stem cells: Of mice and men. Annu Rev Cell Dev Biol 2001; 17: 435-62.
73. Evans M, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981; 292: 154-6.
74. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282: 1145-7.
75. Wobus AM, Boheler KR. Embryonic stem cells: Prospects for developmental biology and cell therapy. Physiol Rev 2005; 85: 635-78.
76. Murry CE, Keller G. Differentiation of embryonic stem cells to clinically relevant populations: Lessons from embryonic development. Cell 2008; 132: 661-80.
77. Puc é at M. TGF ?in the differentiation of embryonic stem cells. Cardiovasc Res 2007; 74: 256-61.
78. Seuntjens E, Umans L, Zwijsen A, Sampaolesi M, Verfaillie CM, Huylebroeck D. Transforming growth factor type beta and Smad family signaling in stem cell function. Cytokine Growth Factor Rev 2009; 20: 449-58.
79. Watabe T, Miyazono K. Roles of TGF-?family signaling in stem cell renewal and differentiation. Cell Res 2009; 19: 103-15.
80. Dupont S, Zacchigna L, Cordenonsi M, Soligo S, Adorno M, Rugge M, Piccolo S. Germ-layer specification and control of cell growth by Ectodermin, a Smad4 ubiquitin ligase. Cell 2005; 121: 87-99.
81. Tada S, Era T, Furusawa C, Sakurai H, Nishikawa S, Kinoshita M, Nakao K, Chiba T, Nishikawa S. Characterization of mesendoderm: A diverging point of the definitive endoderm and mesoderm in embryonic stem cell differentiation culture. Development 2005; 132: 4363-74.
82. Park C, Afrikanova I, Chung YS, Zhang WJ, Arentson E, Fong Gh G, Rosendahl A, Choi K. A hierarchical order of factors in the generation of FLK1-And SCL-expressing hematopoietic and endothelial progenitors from embryonic stem cells. Development 2004; 131: 2749-62.
83. Willems E, Leyns L. Patterning of mouse embryonic stem cellderived pan-mesoderm by Activin A/Nodal and Bmp4 signaling requires Fibroblast Growth Factor activity. Differentiation 2008; 76: 745-59.
84. Mahmood A, Harkness L, Schroder HD, Abdallah BM, Kassem M. Enhanced differentiation of human embryonic stem cells to mesenchymal progenitors by inhibition of TGF-beta/activin/nodal signaling using SB-431542. J Bone Miner Res 2010; 25: 1216-33.
85. Sasai Y, Lu B, Piccolo S, De Robertis EM. Endoderm induction by the organizer-secreted factors chordin and noggin in Xenopus animal caps. EMBO J 1996; 15: 4547-55.
86. D Amour KA, Agulnick AD, Eliazer S, Kelly OG, Kroon E, Baetge EE. Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat Biotechnol 2005; 23: 1534-41.
87. Lafl amme MA, Chen KY, Naumova AV, Muskheli V, Fugate JA, Dupras SK, Reinecke H, Xu C, Hassanipour M, Police S, OSullivan C, Collins L, Chen Y, Minami E, Gill EA, Ueno S, Yuan C, Gold J, Murry CE. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 2007; 25: 1015-24.
88. Behfar A, Zingman LV, Hodgson DM, Rauzier JM, Kane GC, Terzic A, Puc é at M. Stem cell differentiation requires a paracrine pathway in the heart. FASEB J 2002; 16: 1558-66.
89. Yuasa S, Itabashi Y, Koshimizu U, Tanaka T, Sugimura K, Kinoshita M, Hattori F, Fukami S, Shimazaki T, Ogawa S, Okano H, Fukuda K. Transient inhibition of BMP signaling by Noggin induces cardiomyocyte differentiation of mouse embryonic stem cells. Nat Biotechnol 2005; 23: 607-11.
90. Nishikawa ST, Nishikawa S, Hirashima M. Progressive lineage analysis by cell sorting and culture identities FLK1+ VE-cadherin+ cells at a diverging point of endothelial and hematopoietic lineages. Development 1998; 125: 1747-57.
91. Levenberg S, Golub JS, Amit M, Itskovitz-Eldor J, Langer R. Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 2002; 99: 4391-6.
92. Chadwick K, Wang L, Li L, Menendez P, Murdoch B, Rouleau A, Bhatia M. Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells. Blood 2003; 102: 906-15.
93. Poon E, Clermont F, Firpo MT, Akhurst RJ. TGF ?inhibition of yolk-sac-like differentiation of human embryonic stem-cellderived embryoid bodies illustrates differences between early mouse and human development. J Cell Sci 2006; 119: 759-68.
94. Gouon-Evans V, Boussemart L, Gadue P, Nierhoff D, Koehler CI, Kubo A, Shafritz DA, Keller G. BMP-4 is required for hepatic specification of mouse embryonic stem cell-derived definitive endoderm. Nat Biotechnol 2006; 24: 1402-11.
95. Schmidt C, Bladt F, Goedecke S, Brinkmann V, Zschiesche W, Sharpe M, Gherardi E, Birchmeier C. Scatter factor/hepatocyte growth factor is essential for liver development. Nature 1995; 373: 699-702.
96. Watanabe K, Kamiya D, Nishiyama A, Katayama T, Nozaki S, Kawasaki H, Watanabe Y, Mizuseki K, Sasai Y. Directed differentiation of telencephalic precursors from embryonic stem cells. Nat Neurosci 2005; 8: 288-96.
97. Ying QL, Stavridis M, Griffi ths D, Li M, Smith A. Conversion of embryonic stem cells into neuroectodermal precursors in adherent monoculture. Nat Biotechnol 2003; 21: 183-6.
98. Yamamoto Y, Oelgeschläger M. Regulation of bone morphogenetic proteins in early embryonic development. Naturwissenschaften 2004; 91: 519-34.
99. Chambers SM, Fasano CA, Papapetrou EP, Tomishima M, Sadelain M, Studer L. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol 2009; 27: 275-80.
100. Mizuseki K, Sakamoto T, Watanabe K, Muguruma K, Ikeya M, Nishiyama A, Arakawa A, Suemori H, Nakatsuji N, Kawasaki H, Murakami F, Sasai Y. Generation of neural crest-derived peripheral neurons and fl oor plate cells from mouse and primate embryonic stem cells. Proc Natl Acad Sci USA 2003; 100: 5828-33.
101. Dreesen O, Brivanlou AH. Signaling pathways in cancer and embryonic stem cells. Stem Cell Rev 2007; 3: 7-17
102. Harley CB, Rao MS. Human embryonic vs. adult stem cells for transplantation therapies. In: Chiu AY, Rao MS, editors. Human embryonic stem cells. Totowa, NJ: Humana Press Inc., 2003: 239-64.
103. Derynck R, Piek E, Schneider RA, Choy L, Alliston T. TGF-?family signaling in mesenchymal differentiation. In: Derynck R, Miyazono K, editors. The TGF-beta family. New York: Cold Spring Harbor Press, 2009: 613-65.
104. Charg é SB, Rudnicki MA. Cellular and molecular regulation of muscle regeneration. Physiol Rev 2004; 84: 209-38.
105. Roelen BA, Dijke P. Controlling mesenchymal stem cell differentiation by TGFBeta family members. Orthop Sci 2003; 8: 740-8.
106. Liu D, Black BL, Derynck R. TGF-beta inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3. Genes Dev 2001; 15: 2950-66.
107. Walsh FS, Celeste AJ. Myostatin: A modulator of skeletalmuscle stem cells. Biochem Soc Trans 2005; 33: 1513-7.
108. Langley B, Thomas M, Bishop A, Sharma M, Gilmour S, Kambadur R. Myostatin inhibits myoblast differentiation by down-regulating MyoD expression. J Biol Chem 2002; 277: 49831-40.
109. Chen D, Zhao M, Mundy GR. Bone morphogenetic proteins. Growth Factors 2004; 22: 233-41.
110. Clever JL, Sakai Y, Wang RA, Schneider DB. Inefficient skeletal muscle repair in inhibitor of differentiation knockout mice suggests a crucial role for BMP signaling during adult muscle regeneration. Am J Physiol Cell Physiol 2010; 298: C1087-99.
111. Ruschke K, Hiepen C, Becker J, Knaus P. BMPs are mediators in tissue crosstalk of the regenerating musculoskeletal system. Cell Tissue Res 2012; 347: 521-44.
112. van der Kraan PM, Blaney Davidson EN, Blom A, van den Berg WB. TGF-beta signaling in chondrocyte terminal differentiation and osteoarthritis: Modulation and integration of signaling pathways through receptor-Smads. Osteoarthritis Cartilage 2009; 17: 1539-45.
113. Ballock RT, Heydemann A, Wakefield LM, Flanders KC, Roberts AB, Sporn MB. TGF-beta 1 prevents hypertrophy of epiphyseal chondrocytes: Regulation of gene expression for cartilage matrix proteins and metalloproteases. Dev Biol 1993; 158: 414-29.
114. Mueller MB, Tuan RS. Functional characterization of hypertrophy in chondrogenesis of human mesenchymal stem cells. Arthritis Rheum 2008; 58: 1377-88.
115. Tuli R, Tuli S, Nandi S, Huang X, Manner PA, Hozack WJ, Danielson KG, Hall DJ, Tuan RS. Transforming growth factorbeta-mediated chondrogenesis of human mesenchymal progenitor cells involves N-cadherin and mitogen-Activated protein kinase and Wnt signaling cross-Talk. J Biol Chem 2003; 278: 41227-36.
116. Ferguson CM, Schwarz EM, Reynolds PR, Puzas JE, Rosier RN, OKeefe RJ. Smad2 and 3 mediate transforming growth factorbeta1-induced inhibition of chondrocyte maturation. Endocrinology 2000; 141: 4728-35.
117. Docheva D, Haasters F, Schieker M. Mesenchymal stem cells and their cell surface receptors. Curr Rheumatol Rev 2008; 4: 155-60.
118. Barry F, Boynton RE, Liu B, Murphy JM. Chondrogenic differentiation of mesenchymal stem cells from bone marrow: Differentiation-dependent gene expression of matrix components. Exp Cell Res 2001; 268: 189-200.
119. Hwang NS, Zhang C, Hwang YS, Varghese S. Mesenchymal stem cell differentiation and roles in regenerative medicine. Wiley Interdiscip Rev Syst Biol Med 2009; 1: 97-106.
120. Sekiya I, Larson BL, Vuoristo JT, Reger RL, Prockop DJ. Comparison of effect of BMP-2,-4, and-6 on in vitro cartilage formation of human adult stem cells from bone marrow stroma. Cell Tissue Res 2005; 320: 269-76.
121. Hanada K, Solchaga LA, Caplan AI, Hering TM, Goldberg VM, Yoo JU, Johnstone B. BMP-2 induction and TGF-beta 1 modulation of rat periosteal cell chondrogenesis. J Cell Biochem 2001; 81: 284-94.
122. Miljkovic ND, Cooper GM, Marra KG. Chondrogenesis, bone morphogenetic protein-4 and mesenchymal stem cells. Osteoarthritis Cartilage 2008; 16: 1121-30.
123. Bai X, Li G, Zhao C, Duan H, Qu F. BMP7 induces the differentiation of bone marrow-derived mesenchymal cells into chondrocytes. Med Biol Eng Comput 2011; 49: 687-92
124. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-7.
125. Noda M, Camilliere JJ. In vivo stimulation of bone formation by transforming growth factor-beta. Endocrinology 1989; 124: 2991-4.
126. Joyce ME, Roberts AB, Sporn MB, Bolander ME. Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femur. J Cell Biol 1990; 110: 2195-207.
127. Erlebacher A, Derynck R. Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype. J Cell Biol 1996; 132: 195-210.
128. Alliston T, Choy L, Ducy P, Karsenty G, Derynck R. TGF-betainduced repression of CBFA1 by Smad3 decreases CBFA1 and osteocalcin expression and inhibits osteoblast differentiation. EMBO J 2001; 20: 2254-72.
129. Zhou S. TGF-beta regulates beta-catenin signaling and osteoblast differentiation in human mesenchymal stem cells. J Cell Biochem 2011; 112: 1651-60.
130. Huang Z, Ren PG, Ma T, Smith RL, Goodman SB. Modulating osteogenesis of mesenchymal stem cells by modifying growth factor availability. Cytokine 2010; 51: 305-10.
131. Wozney JM. Overview of bone morphogenetic proteins. Spine 2002; 27: S2-8.
132. Vukicevic S, Grgurevic L. BMP-6 and mesenchymal stem cell differentiation. Cytokine Growth Factor Rev 2009; 20: 441-8.
133. Chen G, Deng C, Li YP. TGF-?and BMP signaling in osteoblast differentiation and bone formation. Int J Biol Sci 2012; 8: 272-88.
134. Shen B, Bhargav D, Wei A, Williams LA, Tao H, Ma DD, Diwan AD. BMP-13 emerges as a potential inhibitor of bone formation Int J Biol Sci 2009; 5: 192-200.
135. Maeda S, Hayashi M, Komiya S, Imamura T, Miyazono K. Endogenous TGF-beta signaling suppresses maturation of osteoblastic mesenchymal cells. EMBO J 2004; 23: 552-63.
136. Singhatanadgit W, Salih V, Olsen I. Up-regulation of bone morphogenetic protein receptor IB by growth factors enhances BMP-2-induced human bone cell functions. J Cell Physiol 2006; 209: 912-22.
137. Yoshikawa H, Yoshioka K, Nakase T, Itoh K. Stimulation of ectopic bone formation in response to BMP-2 by Rho kinase inhibitor: A pilot study. Clin Orthop Relat Res 2009; 467: 3087-95.
138. Otto TC, Lane MD. Adipose development: From stem cell to adipocyte. Crit Rev Biochem Mol Biol 2005; 40: 229-42.
139. Lowe CE, ORahilly S, Rochford JJ. Adipogenesis at a glance. J Cell Sci 2011; 124: 2681-6.
140. Margoni A, Fotis L, Papavassiliou AG. The transforming growth factor-beta/bone morphogenetic protein signalling pathway in adipogenesis. Int J Biochem Cell Biol 2012; 44: 475-9.
141. Zamani N, Brown CW. Emerging roles for the transforming growth factor-{beta} superfamily in regulating adiposity and energy expenditure. Endocr Rev 2011; 32: 387-403.
142. Choy L, Skillington J, Derynck R. Roles of autocrine TGF-beta receptor and Smad signaling in adipocyte differentiation. J Cell Biol 2000; 49: 667-82.
143. Tsurutani Y, Fujimoto M, Takemoto M, Irisuna H, Koshizaka M, Onishi S, Ishikawa T, Mezawa M, He P, Honjo S, Maezawa Y, Saito Y, Yokote K. The roles of transforming growth factorbeta and Smad3 signaling in adipocyte differentiation and obesity. Biochem Biophys Res Commun 2011; 407: 68-73.
144. Zhang H, Schulz TJ, Espinoza DO, Huang TL, Emanuelli B, Kristiansen K, Tseng YH. Cross talk between insulin and bone morphogenetic protein signaling systems in brown adipogenesis. Mol Cell Biol 2010; 30: 4224-33.
145. Sottile V, Seuwen K. Bone morphogenetic protein-2 stimulates adipogenic differentiation of mesenchymal precursor cells in synergy with BRL 49653 (rosiglitazone). FEBS Lett 2000; 475: 201-4.
146. Hata K, Nishimura R, Ikeda F, Yamashita K, Matsubara T, Nokubi T, Yoneda T. Differential roles of Smad1 and p38 kinase in regulation of peroxisome proliferator-Activating receptor gamma during bone morphogenetic protein 2-induced adipogenesis. Mol Biol Cell 2003; 14: 545-55.
147. Jin W, Takagi T, Kanesashi SN, Kurahashi T, Nomura T, Harada J, Ishii S. Schnurri-2 controls BMP-dependent adipogenesis via interaction with Smad proteins. Dev Cell 2006; 10: 461-71.
148. Taha MF, Valojerdi MR, Mowla SJ. Effect of bone morphogenetic protein-4 (BMP-4) on adipocyte differentiation from mouse embryonic stem cells. Anat Histol Embryol 2006; 35: 271-8.
149. Stewart A, Guan H, Yang K. BMP-3 promotes mesenchymal stem cell proliferation through the TGF-beta/activin signaling pathway. J Cell Physiol 2011; 223: 658-66.
150. Tseng YH, Kokkotou E, Schulz TJ, Huang TL, Winnay JN, Taniguchi CM, Tran TT, Suzuki R, Espinoza DO, Yamamoto Y, Ahrens MJ, DudleyAT, Norris AW, Kulkarni RN, Kahn CR. New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure. Nature 2008; 454: 1000-4.
151. Rebbapragada A, Benchabane H, Wrana JL, Celeste AJ, Attisano L. Myostatin signals through a transforming growth factor beta-like signaling pathway to block adipogenesis. Mol Cell Biol 2003; 23: 7230-42.
152. Feldman BJ, Streeper RS, Farese Jr. RV, Yamamoto KR. Myostatin modulates adipogenesis to generate adipocytes with favorable metabolic effects. Proc Natl Acad Sci USA 2006; 103: 15675-80.
153. Guo W, Flanagan J, Jasuja R, Kirkland J, Jiang L, Bhasin S. The effects of myostatin on adipogenic differentiation of human bone marrow-derived mesenchymal stem cells are mediated through cross-communication between Smad3 and Wnt/beta-catenin signaling pathways. J Biol Chem 2008; 283: 9136-45.
154. Hino J, Miyazawa T, Miyazato M, Kangawa K. Bone morphogenetic protein-3b (BMP-3b) is expressed in adipocytes and inhibits adipogenesis as a unique complex. Int J Obes (Lond) 2012; 36: 725-34.
155. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009; 119: 1420-8.
156. Battula VL, Evans KW, Hollier BG, Shi Y, Marini FC, Ayyanan A, Wang RY, Brisken C, Guerra R, Andreeff M, Mani SA. Epithelial-mesenchymal transition-derived cells exhibit multilineage differentiation potential similar to mesenchymal stem cells. Stem Cells 2010; 28: 1435-45.
157. Goumans MJ, van Zonneveld AJ, ten Dijke P. Transforming growth factor beta-induced endothelial-To-mesenchymal transition: A switch to cardiac fibrosis ? Trends Cardiovasc Med 2008; 18: 293-8.
158. Kuhn NZ, Tuan RS. Regulation of stemness and stem cell niche of mesenchymal stem cells: Implications in tumorigenesis and metastasis. J Cell Physiol 2010; 222: 268-77.
159. Saj A, Lai EC. Control of microRNA biogenesis and transcription by cell signaling pathways. Curr Opin Genet Dev 2011; 21: 504-10.
160. Guo L, Zhao RC, Wu Y. The role of microRNAs in self-renewal and differentiation of mesenchymal stem cells. Exp Hematol 2011; 39: 608-16.
161. Tiscornia G, Izpisúa Belmonte JC. MicroRNAs in embryonic stem cell function and fate. Genes Dev 2010; 24: 2732-41.
162. Graham H, Peng C. Activin receptor-like kinases: Structure, function and clinical implications. Endocr Metab Immune Disord Drug Targets 2006; 6: 45-58.